{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:47:16Z","timestamp":1783129636854,"version":"3.54.6"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s13300-017-0244-9","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T01:12:08Z","timestamp":1489367528000},"page":"659-672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional"],"prefix":"10.1007","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-0067","authenticated-orcid":false,"given":"Sanjay","family":"Kalra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrish","family":"Mithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debmalya","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence J.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"244_CR1","doi-asserted-by":"publisher","unstructured":"Kalra S, Mithal A, Sahay R, et al. Indian Injection technique study: population characteristics and injection practices. Diabetes Ther. 2017. doi: 10.1007\/s13300-017-0243-x .","DOI":"10.1007\/s13300-017-0243-x"},{"key":"244_CR2","doi-asserted-by":"crossref","unstructured":"Frid AH, et al. Worldwide injection technique questionnaire study: population parameters and injection practices. Mayo Clinic Proc. 91(9):1212\u20131223. http:\/\/www.mayoclinicproceedings.org\/article\/S0025-6196(16)30322-6\/fulltext .","DOI":"10.1016\/j.mayocp.2016.06.011"},{"key":"244_CR3","doi-asserted-by":"crossref","unstructured":"Frid AH, et al. Worldwide injection technique questionnaire study: injecting complications and role of the professional. Mayo Clinic Proc. 91(9):1224\u20131230. http:\/\/www.mayoclinicproceedings.org\/article\/S0025-6196(16)30326-3\/fulltext .","DOI":"10.1016\/j.mayocp.2016.06.012"},{"key":"244_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1464-5491.1990.tb01494.x","volume":"7","author":"JC Thow","year":"1990","unstructured":"Thow JC, Johnson AB, Marsden S, Taylor R, Home PH. Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin. Diabet Med. 1990;7:795\u20139.","journal-title":"Diabet Med"},{"key":"244_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","volume":"4","author":"T Richardson","year":"2003","unstructured":"Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4:661\u20137.","journal-title":"Am J Clin Dermatol"},{"key":"244_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/004947559602600406","volume":"26","author":"B Seyoum","year":"1996","unstructured":"Seyoum B, Abdulkadir J. Systematic inspection of insulin injection sites for local complications related to incorrect injection technique. Trop Doct. 1996;26:159\u201361.","journal-title":"Trop Doct"},{"key":"244_CR7","unstructured":"Photographs courtesy of Lourdes Saez-de Ibarra and Ruth Gaspar, Diabetes Nurses and Specialist Educators from La Paz Hospital, Madrid, Spain."},{"issue":"10","key":"244_CR8","first-page":"1196","volume":"15","author":"Z Hajheydari","year":"2011","unstructured":"Hajheydari Z, Kashi Z, Akha O, Akbarzadeh S. Frequency of lipodystrophy induced by recombinant human insulin. Eur Rev Med Pharmacol Sci. 2011;15(10):1196\u2013201.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"244_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/s-2001-18991","volume":"109","author":"K Raile","year":"2001","unstructured":"Raile K, Noelle V, Landgraf R, Schwarz HP. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2001;109(8):393\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"244_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/pdi.91","volume":"17","author":"TM Partanen","year":"2000","unstructured":"Partanen TM, Rissanen A. Insulin injection practices. Pract Diabetes Int. 2000;17:252\u20134.","journal-title":"Pract Diabetes Int"},{"issue":"3","key":"244_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diacare.25.3.634","volume":"25","author":"O Kordonouri","year":"2002","unstructured":"Kordonouri O, Lauterborn R, Deiss D. Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care. 2002;25(3):634.","journal-title":"Diabetes Care"},{"issue":"5","key":"244_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","volume":"39","author":"M Blanco","year":"2013","unstructured":"Blanco M, Hern\u00e1ndez MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445\u201353.","journal-title":"Diabetes Metab"},{"key":"244_CR13","doi-asserted-by":"crossref","unstructured":"Grassi G, Scuntero P, Trepiccioni R, et al. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Transl Endocrinol. 2014;1:145\u2013150","DOI":"10.1016\/j.jcte.2014.07.006"},{"key":"244_CR14","unstructured":"Ji L, Li Q, Wei G. Lipohypertrophy\u2014prevalence, risk factors and clinical characteristics of insulin-requiring patients in China. Abstract, EASD Vienna 2014, Tracking Number: A-14-747."},{"key":"244_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jpeds.2007.10.006","volume":"152","author":"LS Conwell","year":"2008","unstructured":"Conwell LS, Pope E, Artiles AM, Mohanta A, Daneman A, Daneman D. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr. 2008;152:622\u20138.","journal-title":"J Pediatr"},{"key":"244_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/dia.2013.0192","volume":"16","author":"J Pickup","year":"2014","unstructured":"Pickup J, Yemane N, Brackenridge A, Pender S. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diabetes Technol Ther. 2014;16:145\u20139.","journal-title":"Diabetes Technol Ther"},{"key":"244_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2006.12.023","volume":"77","author":"B Vardar","year":"2007","unstructured":"Vardar B, Kizilci S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract. 2007;77:231\u20136.","journal-title":"Diabetes Res Clin Pract"},{"key":"244_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pdi.1960150108","volume":"15","author":"L Saez-de Ibarra","year":"1998","unstructured":"Saez-de Ibarra L, Gallego F. Factors related to lipohypertrophy in insulin-treated diabetic patients: role of educational intervention. Pract Diab Int. 1998;15:9\u201311.","journal-title":"Pract Diab Int"},{"issue":"5","key":"244_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1507\/endocrj.52.623","volume":"52","author":"J Fujikura","year":"2005","unstructured":"Fujikura J, Fujimoto M, Yasue S, et al. Insulin-induced lipohypertrophy: report of a case with histopathology. Endocr J. 2005;52(5):623\u20138.","journal-title":"Endocr J"},{"key":"244_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2337\/diacare.7.5.479","volume":"7","author":"RJ Young","year":"1984","unstructured":"Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care. 1984;7:479\u201380.","journal-title":"Diabetes Care"},{"key":"244_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bmj.327.7411.383","volume":"327","author":"TA Chowdhury","year":"2003","unstructured":"Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced lipohypertrophy. Brit Med J. 2003;327:383\u20134.","journal-title":"Brit Med J"},{"key":"244_CR22","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2337\/diacare.28.8.2025","volume":"28","author":"UB Johansson","year":"2005","unstructured":"Johansson UB. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care. 2005;28:2025\u20137.","journal-title":"Diabetes Care"},{"key":"244_CR23","unstructured":"Frid A, Linden B. Computed tomography of injection sites in patients with diabetes mellitus. Injection and absorption of insulin, Thesis. Stockholm; 1992."},{"issue":"Suppl 1","key":"244_CR24","first-page":"A615","volume":"40","author":"I Franzen","year":"1997","unstructured":"Franzen I, Ludvigsson J. Specific instructions gave reduction of lipomas and improved metabolic control in diabetic children. Diabetologia. 1997;40(Suppl 1):A615.","journal-title":"Diabetologia"},{"key":"244_CR25","unstructured":"Li Q, Ji L, Sun Z, et al. Lipohypertrophy (LH) prevalence varies widely between chinese cities\u2014need for consistent LH diagnostic methods. Abstract submitted to 2015 ADA (2015)."},{"key":"244_CR26","unstructured":"Famulla S, H\u00f6velmann U, Fischer A, et al. Lipohypertrophy (LHT) leads to blunted, more variable insulin absorption and action in patients with type 1 diabetes (T1DM). Abstract, 2015 ADA in Boston, USA (2015)."},{"key":"244_CR27","unstructured":"Hovelmann U, Famulla S, Hermanski L, et al. Insulin injection into regions with lipohypertrophy (LHT) worsens postprandial (PP) blood glucose (BG) versus injections into normal adipose tissue (NAT). Abstract, 2015 ADA in Boston, USA (2015)."},{"key":"244_CR28","first-page":"66","volume":"54","author":"J Ahern","year":"2001","unstructured":"Ahern J, Mazur ML. Site rotation. Diabetes Forecast. 2001;54:66\u20138.","journal-title":"Diabetes Forecast"},{"key":"244_CR29","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1001\/jama.1990.03440130090031","volume":"263","author":"JP Bantle","year":"1990","unstructured":"Bantle JP, Weber MS, Rao SM, Chattopadhyay MK, Robertson RP. Rotation of the anatomic regions used for insulin injections day-to-day variability of plasma glucose in type 1 diabetic subjects. JAMA. 1990;263:1802\u20136.","journal-title":"JAMA"},{"key":"244_CR30","first-page":"54","volume":"45","author":"ED Davis","year":"1992","unstructured":"Davis ED, Chesnaky P. Site rotation\u2026taking insulin. Diabetes Forecast. 1992;45:54\u20136.","journal-title":"Diabetes Forecast"},{"issue":"1","key":"244_CR31","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/j.diabres.2007.12.026","volume":"80","author":"MI Olmo Del","year":"2008","unstructured":"Del Olmo MI, Campos V, Abell\u00e1n P, Merino-Torres JF, Pi\u00f1\u00f3n F. A case of lipoatrophy with insulin detemir. Diabetes Res Clin Pract. 2008;80(1):e20\u20131.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"244_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2337\/diacare.27.2.625","volume":"27","author":"A Arranz","year":"2004","unstructured":"Arranz A, Andia V, L\u00f3pez-Guzm\u00e1n A. A case of lipoatrophy with lispro insulin without insulin pump therapy. Diabetes Care. 2004;27(2):625\u20136.","journal-title":"Diabetes Care"},{"issue":"4","key":"244_CR33","first-page":"83","volume":"22","author":"V Breznik","year":"2013","unstructured":"Breznik V, Kokol R, Luzar B, Miljkovi\u0107 J. Insulin-induced localized lipoatrophy. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(4):83\u20135.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"3","key":"244_CR34","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.2337\/dc11-2135","volume":"35","author":"HT Swelheim","year":"2012","unstructured":"Swelheim HT, Westerlaken C, van Pinxteren-Nagler E, Bocca G. Lipoatrophy in a girl with type 1 diabetes: beneficial effects of treatment with a glucocorticoid added to an insulin analog. Diabetes Care. 2012;35(3):e22.","journal-title":"Diabetes Care"},{"issue":"1","key":"244_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/adc.2010.183731","volume":"96","author":"A Babiker","year":"2011","unstructured":"Babiker A, Datta V. Lipoatrophy with insulin analogues in type I diabetes. Arch Dis Child. 2011;96(1):101\u20132.","journal-title":"Arch Dis Child"},{"issue":"2","key":"244_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1517\/14740330903496402","volume":"9","author":"A Holstein","year":"2010","unstructured":"Holstein A, Stege H, Kovacs P. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Expert Opin Drug Saf. 2010;9(2):225\u201331.","journal-title":"Expert Opin Drug Saf"},{"key":"244_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/0009922810384721","volume":"50","author":"KA Brady","year":"2011","unstructured":"Brady KA, Avner JR, Khine H. Perception and attitude of providers towards pain and anxiety associated with pediatric vaccine injection. Clin Pediatr. 2011;50:140\u20133.","journal-title":"Clin Pediatr"},{"key":"244_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1499-2671(11)53012-6","volume":"35","author":"S Diamond","year":"2011","unstructured":"Diamond S, Matok I. Pharmacists\u2019 anticipated pain compared to experienced pain associated with insulin pen injection and fingertip. Can J Diabetes. 2011;35:282\u20136.","journal-title":"Can J Diabetes"},{"issue":"10","key":"244_CR39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/dom.12304","volume":"16","author":"T Heise","year":"2014","unstructured":"Heise T, Nosek L, Dellweg S, et al. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial. Diabetes Obes Metab. 2014;16(10):971\u20136.","journal-title":"Diabetes Obes Metab"},{"key":"244_CR40","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00415-010-5779-x","volume":"257","author":"G Anderson","year":"2010","unstructured":"Anderson G, Meyer D, Herrman CE, et al. Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study. J Neurol. 2010;257:1917\u201323.","journal-title":"J Neurol"},{"key":"244_CR41","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/106002809603000703","volume":"30","author":"JT Jorgensen","year":"1996","unstructured":"Jorgensen JT, Romsing J, Rasmussen M, Moller-Sonnergaard J, Vang L, Musaeus L. Pain assessment of subcutaneous injections. Ann Pharmacother. 1996;30:729\u201332.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"244_CR42","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.2337\/dc10-0871","volume":"33","author":"PL Hofman","year":"2010","unstructured":"Hofman PL, Derraik JG, Pinto TE, et al. Defining the ideal injection techniques when using 5-mm needles in children and adults. Diab Care. 2010;33(9):1940\u20134.","journal-title":"Diab Care"},{"issue":"3","key":"244_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/2230-8210.152762","volume":"19","author":"N Tandon","year":"2015","unstructured":"Tandon N, Kalra S, Balhara YS, et al. Forum for injection technique (FIT), India: the Indian recommendations 2.0, for best practice in insulin injection technique, 2015. Indian J Endocr Metab. 2015;19(3):317\u201331.","journal-title":"Indian J Endocr Metab"},{"key":"244_CR44","first-page":"376","volume":"12","author":"A Mujika-Zabaleta","year":"2010","unstructured":"Mujika-Zabaleta A, et al. Relationship between diabetes knowledge, glycaemic control and quality of life: pilot study. Diabetes Prim Care. 2010;12:376\u201381.","journal-title":"Diabetes Prim Care"},{"issue":"3","key":"244_CR45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/dmrr.798","volume":"24","author":"A Golay","year":"2008","unstructured":"Golay A, Lagger G, Chambouleyron M, Carrard I, Lasserre-Moutet A. Therapeutic education of diabetic patients. Diabetes Metab Res Rev. 2008;24(3):192\u20136. doi: 10.1002\/dmrr.798 .","journal-title":"Diabetes Metab Res Rev"},{"key":"244_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pdi.314","volume":"19","author":"K Strauss","year":"2002","unstructured":"Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19:71\u20136.","journal-title":"Pract Diab Int"},{"key":"244_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1477-7525-5-53","volume":"5","author":"L Martinez","year":"2007","unstructured":"Martinez L, Consoli SM, Monnier L, et al. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire. Health Qual Life Out. 2007;5:53.","journal-title":"Health Qual Life Out"},{"key":"244_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/dia.2008.0249","volume":"10","author":"WT Cefalu","year":"2008","unstructured":"Cefalu WT, Mathieu C, Davidson J, et al. Patients\u2019 perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diab Tech Ther. 2008;10:25\u201338.","journal-title":"Diab Tech Ther"},{"key":"244_CR49","first-page":"233","volume-title":"Achieving patient compliance. The psychology of medical practitioner\u2019s role","year":"1982","unstructured":"DiMatteo RM, DiNicola DD, editors. Achieving patient compliance. The psychology of medical practitioner\u2019s role. Oxford: Pergamon; 1982. p. 233\u201356."},{"key":"244_CR50","doi-asserted-by":"publisher","first-page":"54S","DOI":"10.1177\/0145721708319233","volume":"34","author":"SV Joy","year":"2008","unstructured":"Joy SV. Clinical pearls and strategies to optimize patient outcomes. Diabetes Educator. 2008;34:54S\u20139S.","journal-title":"Diabetes Educator"},{"key":"244_CR51","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.2337\/dc08-1283","volume":"31","author":"M Davidson","year":"2008","unstructured":"Davidson M. No need for the needle (at first). Diabetes Care. 2008;31:2070\u20131.","journal-title":"Diabetes Care"},{"key":"244_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.diabet.2008.02.008","volume":"34","author":"G Reach","year":"2008","unstructured":"Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diab Metab. 2008;34:382\u20135.","journal-title":"Diab Metab"},{"key":"244_CR53","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1464-5491.1992.tb01820.x","volume":"9","author":"NM Genev","year":"1992","unstructured":"Genev NM, Flack JR, Hoskins PL, et al. Diabetes education: whose priorities are met? Diab Med. 1992;9:475\u20139.","journal-title":"Diab Med"},{"key":"244_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/15209150152811261","volume":"3","author":"DC Klonoff","year":"2001","unstructured":"Klonoff DC. The pen is mightier than the needle (and syringe). Diab Tech Ther. 2001;3:631\u20133.","journal-title":"Diab Tech Ther"},{"key":"244_CR55","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","volume":"49","author":"L Heinemann","year":"2006","unstructured":"Heinemann L, Hompesch M, Kapitza C, Harvey NG, Ginsberg BH, Pettis RJ. Intra-dermal insulin lispro application with a new microneedle delivery system led to a substantially more rapid insulin absorption than subcutaneous injection. Diabetologia. 2006;49:755 (abstract 1014).","journal-title":"Diabetologia"},{"key":"244_CR56","unstructured":"ITQ survey data. Tableau Public Adam Young\u2019s Profile website. http:\/\/tabsoft.co\/23V6ofi . Accessed 8 June 2016."}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-017-0244-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-017-0244-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-017-0244-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T13:03:13Z","timestamp":1568898193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-017-0244-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1007\/s13300-017-0244-9","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}